Formulations of vimseltinib

MX2026006913APending Publication Date: 2026-10-02DECIPHERA PHARMACEUTICALS LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MX2026006913
Authority / Receiving Office
MX · MX
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-06
Filing Date
2026-06-05
Publication Date
2026-10-02
Patent Text Reader

Abstract

Described herein, in part, are pharmaceutically acceptable formulations comprising a compound represented by Formula (I) and methods of preparing and using the formulations:
Need to check novelty before this filing date? Find Prior Art